default author photo

Tiziana Pia Latiano

Fondazione IRCCS Casa Sollievo della Sofferenza

Foggia

Italy

SCHOLARLY PAPERS

2

DOWNLOADS

243

TOTAL CITATIONS

14

Scholarly Papers (2)

1.

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

Number of pages: 126 Posted: 16 Nov 2019
University of Pisa - Department of Oncology, University of Pisa - Department of Oncology, University of Pisa - Department of Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology, ARNAS Garibaldi Catania, Fondazione IRCCS Casa Sollievo della Sofferenza, Ospedale degli Infermi, University Campus Biomedico, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), University of Pisa - Department of Oncology, F. Spaziani Hospital, Università degli Studi di Udine, Fondazione Poliambulanza, Istituto Oncologico Veneto – IRCCS, S. Croce and Carle Teaching Hospital, Government of the Italian Republic (Italy) - National Cancer Institute, University of Pisa - Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, ARNAS Garibaldi Catania, Careggi University Hospital of Florence, University of Messina, University of Pisa - Department of Oncology, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, General Hospital, Prato, University of Naples Federico II, Ente Ospedaliero Ospedali Galliera, AOU Città della Salute e della Scienza di Torino, Massa Carrara, University of Rome Tor Vergata, Azienda Toscana Nord Ovest, IRCCS Ospedale San Martino IST, Candiolo Cancer Institute, Ospedale Santa Maria della Misericordia, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Department of Oncology, University of Pisa, University of Pisa, Careggi University Hospital of Florence, University of Pisa - Department of Oncology and affiliation not provided to SSRN
Downloads 188 (409,459)
Citation 14

Abstract:

Loading...

2.

Stemness Underpinning All Steps of Human Colorectal Cancer Defines the Core of Effective Therapeutic Strategies

Number of pages: 52 Posted: 21 Dec 2018
Fondazione IRCCS Casa Sollievo della Sofferenza - Unit of Cancer Stem Cells, StemGen SpA, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, StemGen SpA, StemGen SpA, Catholic University of the Sacred Heart, Rome, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Fondazione IRCCS Casa Sollievo della Sofferenza, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Catholic University of the Sacred Heart, Rome, StemGen SpA and Opera di San Pio da Pietrelcina - Unit of Cancer Stem Cells
Downloads 55 (1,010,164)

Abstract:

Loading...

Human Colorectal Carcinoma (CRC); Stemness; CRC Stages; CRC Stem Cells; CRC Circulating Stem Cells; CRC Metastatic Stem Cells; anti-CRC SCs strategies